76 related articles for article (PubMed ID: 8846017)
1. In vitro effects of etoposide purging on natural killer cells.
Silva MR; Ascensao JL
J Hematother; 1995 Dec; 4(6):563-70. PubMed ID: 8846017
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
3. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
Ericson SG; Colby E; Welch L; Ball ED
Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
[TBL] [Abstract][Full Text] [Related]
4. Generation of human natural killer cells from pharmacologically purged bone marrow.
Silva MR; Ascensao JL
Br J Haematol; 1995 Jan; 89(1):34-40. PubMed ID: 7833274
[TBL] [Abstract][Full Text] [Related]
5. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
7. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia.
Beaujean F; Bernaudin F; Kuentz M; Lemerle S; Cordonnier C; Le Forestier C; Reinert P; Duedari N; Brandely M; Vernant JP
Bone Marrow Transplant; 1995 May; 15(5):691-6. PubMed ID: 7670397
[TBL] [Abstract][Full Text] [Related]
8. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
Miller G; Brashear T; Stone M; Fay J
Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
[TBL] [Abstract][Full Text] [Related]
9. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
Damon LE; Rugo HS; Ries CA; Linker CA
Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging.
Zhong RK; Donnenberg AD; Rubin J; Ball ED
Blood; 1994 Apr; 83(8):2345-51. PubMed ID: 7512845
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
[TBL] [Abstract][Full Text] [Related]
14. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
15. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
[TBL] [Abstract][Full Text] [Related]
16. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
Kühl JS; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
[TBL] [Abstract][Full Text] [Related]
17. Effect of pharmacological purging on natural killer cell number and activity in human bone marrow.
Cardoso AA; Fallon M; Mukherji B; Silva MR; Marusic M; Gaffney J; Ascensao JL
Clin Immunol Immunopathol; 1992 Aug; 64(2):106-11. PubMed ID: 1643743
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
Gulati S; Acaba L; Yahalom J; Reich L; Motzer R; Crown J; Doherty M; Clarkson B; Berman E; Atzpodien J
Bone Marrow Transplant; 1992 Aug; 10(2):129-34. PubMed ID: 1525601
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Motta MR; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli RM
Exp Hematol; 1997 Nov; 25(12):1261-9. PubMed ID: 9357970
[TBL] [Abstract][Full Text] [Related]
20. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]